The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Retrospective analysis of cardiovascular (CV) events following compassionate use of carfilzomib (CFZ) in patients (Pts) with relapsed and refractory multiple myeloma (RRMM).
Shebli Atrash
No relevant relationships to disclose
Amanda Tullos
No relevant relationships to disclose
Susan Panozzo
No relevant relationships to disclose
Sarah Waheed
No relevant relationships to disclose
Frits Van Rhee
No relevant relationships to disclose
Alejandro Restrepo
No relevant relationships to disclose
Jameel Muzaffar
No relevant relationships to disclose
Aziz Bakhous
No relevant relationships to disclose
Monica Grazziutti
No relevant relationships to disclose
Zainab Shahid
No relevant relationships to disclose
Senu Apewokin
No relevant relationships to disclose
Al-Ola A. Abdallah
No relevant relationships to disclose
Bart Barlogie
Consultant or Advisory Role - Celgene; Millennium
Research Funding - Celgene; Millennium
Saad Zafar Usmani
Consultant or Advisory Role - Celgene
Research Funding - Celgene; Millennium; Onyx